Western Australia has expanded the prescribing powers of designated registered nurse prescribers and qualified pharmacists through the Medicines and Poisons Amendment Regulations (No. 2) 2026, published on 28 October 2026. The amendments allow nurses with the appropriate endorsement to prescribe and administer a wider range of medicines, while qualified pharmacists gain authority to prescribe certain medicines under strict conditions.
What changed
The new regulations update the Medicines and Poisons Regulations 2016 to:
- Authorise designated registered nurse prescribers - registered nurses endorsed under WA’s Health Practitioner Regulation National Law - to supply Schedule 2 and 3 poisons, and to administer, possess, prescribe, and supply Schedule 4 and Schedule 8 poisons, with Schedule 8 prescriptions subject to additional controls.
- Permit qualified pharmacists to prescribe Schedule 4 poisons only, subject to conditions including:
- Prescription must occur at a registered pharmacy.
- The pharmacist must hold a CEO-approved qualification at AQF level 8 or higher accredited by the Australian Pharmacy Council.
- Prescriptions must comply with CEO-approved clinical practice guidelines for the relevant health condition.
These prescribing expansions come into effect the day after publication (29 October 2026) for most provisions, with specific pharmacist qualification and guideline approvals commencing on 30 November 2026.
| Professional Group | Poison Schedules Authorized |
|---|---|
| Designated Registered Nurse Prescriber | Schedules 2, 3, 4, and 8 (with conditions) |
| Qualified Pharmacists | Schedule 4 only (with CEO-approved qualifications and clinical guidelines) |
Want to follow this thread yourself? Search GovScanner's free dashboard, or connect GovScanner to your favourite AI so your model can explore WA government data for you.
Source trail
The changes are established in the Medicines and Poisons Amendment Regulations (No. 2) 2026, made under the Medicines and Poisons Act 2014 and published on the WA legislation website on 28 October 2026. The regulations amend key definitions and insert new authorisation provisions for designated nurse prescribers and pharmacists, with commencement dates specified in the document. The CEO of the Department of Health is empowered to approve both qualifications and clinical practice guidelines relevant to pharmacist prescribing. Medicines and Poisons Amendment Regulations (No. 2) 2026
Watch next
The CEO’s approval of pharmacist qualifications and clinical practice guidelines, required for pharmacists to prescribe Schedule 4 medicines, will take effect on 30 November 2026. Stakeholders should monitor the Department of Health’s publications for these approvals, which will determine the operational scope for pharmacist prescribers.
Find your own data
Want to explore this thread yourself? Search the free GovScanner dashboard, or connect GovScanner directly to your favourite AI so your model can investigate WA government data for you. It is quick to connect, and it gives your AI raw access to structured WA government records instead of making it hunt through PDFs and webpages from scratch.
